Authors:
Sweetenham, J
Hieke, K
Kerrigan, M
Howard, P
Smartt, PFM
McIntyre, AM
Townshend, S
Citation: J. Sweetenham et al., Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the UK, BR J HAEM, 106(1), 1999, pp. 47-54